AGF Management Ltd. Takes $2.54 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

AGF Management Ltd. bought a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 133,546 shares of the medical instruments supplier's stock, valued at approximately $2,535,000. AGF Management Ltd. owned 0.07% of DENTSPLY SIRONA as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Riverview Trust Co acquired a new position in shares of DENTSPLY SIRONA in the fourth quarter worth $26,000. MassMutual Private Wealth & Trust FSB boosted its holdings in DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after purchasing an additional 1,232 shares during the period. UMB Bank n.a. grew its stake in DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after purchasing an additional 564 shares in the last quarter. Van ECK Associates Corp purchased a new stake in DENTSPLY SIRONA during the 3rd quarter worth about $42,000. Finally, Venturi Wealth Management LLC increased its holdings in DENTSPLY SIRONA by 4,893.5% during the 3rd quarter. Venturi Wealth Management LLC now owns 2,297 shares of the medical instruments supplier's stock worth $62,000 after purchasing an additional 2,251 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of the firm's stock in a transaction dated Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the purchase, the director now owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.52% of the company's stock.

DENTSPLY SIRONA Stock Down 2.2 %

Shares of NASDAQ XRAY opened at $15.00 on Friday. The business has a 50-day moving average price of $18.35 and a 200 day moving average price of $20.97. The stock has a market cap of $2.98 billion, a PE ratio of -7.25, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 52-week low of $14.77 and a 52-week high of $34.16.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 4.27%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA's payout ratio is currently -14.07%.

Wall Street Analysts Forecast Growth

XRAY has been the subject of a number of analyst reports. Wells Fargo & Company lowered their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. StockNews.com cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and reduced their price objective for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Morgan Stanley decreased their price objective on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a research report on Tuesday, December 17th. Finally, Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday. Twelve equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $23.33.

Remove Ads

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.